Quote:
Originally Posted by jmt18325
We don't need to wait that long anymore. A vaccine with 90% effectiveness is in sight. We should be leaving isolation requirements in effect until that time.
|
Some of the vaccine trials
early data does seem promising, but we are along ways off from actually receiving shots. The very earliest candidates (Oxford's is the most far-ahead, as far as I know) have only just entered Phase II/III of the trials, with the actual testing to be completed this fall/early winter. The actual analysis of the data likely won't be completed until early 2021.
Assuming that it goes well, the Oxford candidate has already begun manufacturing with a partner in India, and could have 10-20 million doses ready for late 2020/early 2021. The main issues is going to be scaling that up.
The first doses will undoubtedly go to the UK, and first to doctors/nurses, and then to the most at risk, and then to the public in general. The most optimistic assessments are that the general public in rich, western nations won't receive the vaccine until late 2021, with the developing world not receiving it until 2022 or 2023. Billions of doses will be required, and it is likely that everyone will require two shots (initial plus a booster a few weeks/months later).
We are still years away from normalcy, I think.